Parikh Anand Kiran — SEC Form 4 filings
SEC reporting owner CIK 2111813. 5 Form 4 filings on record with FilingPulse; latest filed 2026-07-23.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2026-02-19 to 2026-07-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 2,806 shares, $55,447 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 2,806 shares @ $19.76 ($55,447) in Faeth Therapeutics, Inc., filed 2026-06-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | President and CEO, Director | 5 | 1 leg · 2,806 sh · $55,447 | — | 14 |
Form 4 filings — Parikh Anand Kiran
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-23 | 4 | Faeth Therapeutics, Inc. (FTH) | Grant/award (A): 398,018 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | Faeth Therapeutics, Inc. (FTH) | Purchase (P): 2,806 @ $19.76 · Option exercise (M): 45,252 @ $1.16 · Option exercise (M): 8,213 @ $1.16 · Option exercise (M): 45,252 (derivative) @ $0 · Option exercise (M): 8,213 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4/A | Sensei Biotherapeutics, Inc. (FTH) | Grant/award (A): 761.43 (derivative) · Grant/award (A): 12,320 (derivative) · Grant/award (A): 136,884 (derivative) | EDGAR |
| 2026-06-16 | 4 | Sensei Biotherapeutics, Inc. (FTH) | Conversion (C): 761,428 · Conversion (C): 761.43 (derivative) | EDGAR |
| 2026-02-19 | 4 | Sensei Biotherapeutics, Inc. (SNSE) | Grant/award (A): 809,822 (derivative) · Grant/award (A): 92,533 (derivative) · Grant/award (A): 56,673 (derivative) · Grant/award (A): 1,239,305 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2111813 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →